SPONSOR
The Methodist Hospital Research Institute
Total Trials
10
Recruiting
10
Phases
Phase 2, Phase 3, Phase 4, Phase 1, Phase 2
Conditions studied: Patulous Eustachian Tube DysfunctionEustachian Tube DysfunctionACL ReconstructionHigh-risk Prostate CancerProstate CancerKidney TransplantationFrailtyChronic Kidney InsufficiencyBrain Cancer MetastaticCMV Viremia
The Methodist Hospital Research Institute is a clinical research sponsor with 10 registered studies on ClinicalTrials.gov, of which 10 are actively recruiting participants. Research covers conditions including Patulous Eustachian Tube Dysfunction, Eustachian Tube Dysfunction, ACL Reconstruction, High-risk Prostate Cancer.
The trial portfolio spans Phase 2, Phase 3, Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — The Methodist Hospital Research Institute
How many clinical trials has The Methodist Hospital Research Institute sponsored?
ClinicalMetric currently tracks 10 clinical trials sponsored by The Methodist Hospital Research Institute, of which 10 are actively recruiting participants. These trials cover conditions including Patulous Eustachian Tube Dysfunction, Eustachian Tube Dysfunction, ACL Reconstruction. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does The Methodist Hospital Research Institute research focus on?
The Methodist Hospital Research Institute clinical trials span Patulous Eustachian Tube Dysfunction, Eustachian Tube Dysfunction, ACL Reconstruction, High-risk Prostate Cancer, Prostate Cancer, and additional conditions. The research pipeline includes Phase 2, Phase 3, Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a The Methodist Hospital Research Institute clinical trial?
To participate in a The Methodist Hospital Research Institute trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all The Methodist Hospital Research Institute trials with current recruitment status updated daily.
Clinical Trials by The Methodist Hospital Research Institute
NCT07796139
Recruiting
Nasal Dilator Therapy for Patulous Eustachian Tube Dysfunction
Patulous Eustachian Tube Dysfunction
NCT06311058
Recruiting
Protein Supplementation After ACL Surgery
ACL Reconstruction
NCT03541928 Phase 2
Recruiting
Phase II High Risk Prostate Cancer Trial Using Gene & Androgen Deprivation Therapies, Radiotherapy, & Surgery
High-risk Prostate Cancer
NCT06886256
Recruiting
Prehabilitation for Kidney Transplant Candidates
Kidney Transplantation
NCT07383649 Phase 2
Recruiting
Trial to Study Anti- HCMV Therapy in Breast Cancer Patients With Progressive Intracranial Metastases and CMV Infection
Brain Cancer Metastatic
NCT07218484
Recruiting
VoiceLove Digital Therapy for Delirium in the ICU
Delirium
NCT07290491 Phase 3
Recruiting
Spiritual Care or Psychotherapy Versus Palliative Care Alone in Patients With Non-Curative Malignancies
Cancer
NCT06384651 Phase 4
Recruiting
Intraosseous vs. Intravenous Vancomycin Administration in Total Ankle Arthroplasty
Infections
NCT03971487 Phase 1, Phase 2
Recruiting
Ocrelizumab for Psychosis by Autoimmunity
Schizo-Affective Type of Psychosis
NCT05660083 Phase 2
Recruiting
Alpelisib/iNOS Inhibitor/Nab-paclitaxel in Patients With HER2 Negative Metaplastic Breast Cancer (MpBC)
HER2-negative Breast Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology